A revolutionary new cancer treatment is now available in Canada, but provinces are being advised not to cover it until the price comes down — a price that is being kept secret from Canadians. It's a form of CAR-T immunotherapy, in which a patient's blood cells are removed, reprogrammed to attack cancer and then re-injected back into their body. Cost of CAR-T therapy kept secretRight now, Canadians don't know how much Kymriah will cost because the price was blacked out in the report released to the public. "We are exploring innovative ways we can support health system stakeholders, including innovative pricing models, early access mechanisms, risk-sharing with payers, and patient and caregiver support," said Weatherby. John Bell is researching a made-in-Canada CAR-T therapy at the Ottawa Hospital Research Institute.

Source: CBC News January 19, 2019 14:00 UTC